Apr 09, 2020
Collaborative R&D Partnering Deals in Pharma, Biotech & Diagnostics 2014-2020: A Comprehensive Listing of 5,000+ Collaborative R&D Deals
Mar 31, 2020
Over 35 Companies in Race to Develop Vaccine for COVID-19 Health Crises
Mar 18, 2020
Jodi Gurney Named Chief Executive Officer of Direct Biologics LLC
Mar 17, 2020
Medicxi Bolsters and Expands Team with Senior Industry Leaders
Mar 16, 2020
Preclinical Stage Partnering Deals in Pharma & Biotech, 2014-2020 - Access to 1,400+ Deal Records; Leading Deals by Value, Most Active Dealmakers
Mar 16, 2020
Sutro Biopharma Reports Full Year 2019 Financial Results and Recent Business Highlights and Developments
Mar 11, 2020
Clinical Stage Partnering Deals in Pharma & Biotech, 2014-2020 - Access to Over 2,000 Global Clinical Stage Deals
Mar 05, 2020
Outlook on the $320M+ Bladder Cancer Drugs Market, 2020-2030
Mar 04, 2020
The World Market for Cervical Cancer Drugs, Forecast to 2030 - Insights Into Avastin, Bevacizumb, Blemocin, Blenoxane, and More
Mar 02, 2020
Primmune Therapeutics Raises $7 Million Seed Financing to Develop Novel Oral TLR7 Immunotherapies for Cancer and Acute Viral Diseases
Mar 02, 2020
Primmune Therapeutics Raises $7 Million Seed Financing to Develop Novel Oral TLR7 Immunotherapies for Cancer and Acute Viral Diseases
Feb 27, 2020
Sutro Biopharma to Present at the Cowen and Company 40th Annual Health Care Conference
Feb 24, 2020
Top 10 Cancer Drugs Market Study, 2018-2026 - Keytruda Anticipated to Grow at the Highest Rate
Feb 18, 2020
Global ADC Linker & Conjugation Technologies Markets to 2030 - Featuring Executive Insights from Stakeholders in Miracogen, NBE Therapeutics, Synaffix and EUCODIS Bioscience
Feb 05, 2020
Top 10 Cancer Drugs Market to Reach $129.94 Bn, Globally, by 2026 at 9.8% CAGR: Allied Market Research
Feb 05, 2020
Sutro Biopharma Expands Senior Management Team with the Appointments of Vice President of Immunobiology and Vice President of Business Development
Feb 03, 2020
$100+ Billion Immuno-Oncology Market Insights, 2022 - Opdivo and Keytruda Presents Significant Growth Opportunity
Jan 13, 2020
Recognized industry leaders Richard Champlin, John Hood and Andrew Lowy join Cytonus' Scientific Advisory Board
Jan 10, 2020
Tyra Biosciences raises $50M to develop therapies targeting acquired resistance in oncology
Jan 09, 2020
Sutro Biopharma to Present at 38th Annual J.P. Morgan Healthcare Conference